Exforge antitrust settlement caps Novartis’ year of legal disputes
Pharmaceutical Technology
JANUARY 6, 2023
This class-action litigation specifically focused on a 2011 licensing agreement between the two companies. District Judge Kimba Wood dismissed a whistleblower lawsuit against Novartis, that claimed the company had bribed doctors with kickbacks at speaker programs to incentivise doctors to prescribe Gilenya.
Let's personalize your content